ArticleOncotarget2017

Targeting P-glycoprotein function, p53 and energy metabolism: Combination of metformin and 2-deoxyglucose reverses the multidrug resistance of MCF-7/Dox cells to doxorubicin.

Chaojun Xue et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.